Clinical Trials Directory

Trials / Completed

CompletedNCT04236375

Eye Movement and Cognitive Dysfunction

The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
1,539 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

There is association between eye movement disorder and cognitive dysfunction. Therefore, utilizing eye movement and screening for cognitive dysfunction is feasible. In the present study, the investigators will develop an artificial intelligence platform to screening for cognitive dysfunction by inspecting the function of eye movement. Futher more, based on the screening results, the platform will offer referral suggestions.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2025-07-30
Completion
2025-07-30
First posted
2020-01-22
Last updated
2026-04-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04236375. Inclusion in this directory is not an endorsement.

Eye Movement and Cognitive Dysfunction (NCT04236375) · Clinical Trials Directory